AKEBIA THERAPEUTICS, INC. Convertible Preferred Stock Converted to Other Securities
AKEBIA THERAPEUTICS, INC. (AKBA) reported Convertible Preferred Stock Converted to Other Securities of $4.94 million for the 85-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities · last filed 2016-03-14
- AKEBIA THERAPEUTICS, INC. convertible preferred stock converted to other securities for the quarter ending 2013-12-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. convertible preferred stock converted to other securities for fiscal 2013 was $4.94M.
| Period end | Convertible Preferred Stock Converted to Other Securities 3 month | Convertible Preferred Stock Converted to Other Securities 9 month | Convertible Preferred Stock Converted to Other Securities 12 month | Convertible Preferred Stock Converted to Other Securities 85 month |
|---|---|---|---|---|
| 2014-03-31 | $4.94M 10-Q · filed 2014-05-12 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $4.94M 10-K · filed 2016-03-14 | ||
| 2013-09-30 | $4.94M 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |